Price $126.79 |
Market Cap
227.79B
|
Sector Health Care |
Div. Growth
19.10%
|
|
P/E
36.1
|
P/B
6.79
|
P/S
5.7
|
Dividend %
1.40%
|
|
P/CF
59.3
|
P/FCF
40.1
|
Op. Cash Flow
10.63M
|
FCF
3.2
|
|
Op. Margin
18.60%
|
Net Margin
15.80%
|
ROE
19.40%
|
ROI
9.70%
|
|
ROA
8.90%
|
EPS Growth
104.30%
|
Current Ratio
1.7
|
Debt/Equity
56.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cidara Therapeutics Inc (CDTX) | $2.13 | - | - | 107.4M | Strong Buy |
| Recro Pharma Inc (REPH) | $2.24 | - | - | 114M | Strong Buy |
| Psychemedics Corp. (PMD) | $7.83 | - | - | 43.1M | Strong Buy |
| Concert Pharmaceuticals Inc (CNCE) | $3.71 | - | - | 121M | Strong Buy |
| Lannett Company, Inc. (LCI) | $3.07 | - | - | 148.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
